Takeaway

• The addition of venetoclax to the standard daunorubicin/cytarabine induction regimen significantly boosts complete remission (CR) rates after 1 treatment cycle in adults with acute myeloid leukemia (AML).

Why this matters

• Cytarabine plus an anthracycline has been used as the standard AML induction regimen for over 40 years, but the proportion of...